| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 16.95M | — |
| Operating expense | — | — |
| Net income | -46.66M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GOSS returned -93.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -95.0% |
| 1 year | -93.4% |
| 5 years | -98.4% |
| All-time high | $25.50 (Nov 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in GOSS would be worth today ›No. Gossamer Bio, Inc. has not paid a dividend in the past 12 months.
Gossamer Bio, Inc. stock trades on NASDAQ under the ticker symbol GOSS.
Gossamer Bio, Inc. is part of the Healthcare sector.
Gossamer Bio, Inc. has a market cap of 75.62M USD, based on the latest quote.
Gossamer Bio, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
